a r t I C l e S Alzheimer's disease is the most common cause of dementia and currently lacks disease-modifying therapy. The incidence of Alzheimer's disease has been escalating considerably as the population ages, and this has the potential to evolve into a global public health crisis if it continues unchecked [1] [2] [3] . Numerous studies over the past decade suggest that Alzheimer's disease is a disorder of synaptic dysfunction resulting from the toxic effects of amyloid beta (here referred to as Aβ), a short peptide derived from amyloid precursor protein (APP) 4 . In contrast, it has been established that de novo protein synthesis is indispensable for long-lasting synaptic plasticity and the formation of long-term memory 5, 6 . It is unknown whether dysregulated translation contributes to synaptic dysfunction and memory impairments associated with Alzheimer's disease. eIF2 is important in the regulation of protein synthesis, and alterations in the phosphorylation of eIF2α can cause memory impairments [7] [8] [9] . Four kinases, PKR, HRI, GCN2 and PERK, can phosphorylate eIF2α, which results in inhibition of general mRNA translation and enhanced translation of selective mRNAs such as the transcriptional regulator ATF4, a repressor of long-term synaptic plasticity and memory 8, 10, 11 . Elevated eIF2α phosphorylation has been correlated with pathogenesis of Alzheimer's disease [12] [13] [14] , but its link to synaptic failure and memory defects in Alzheimer's disease is unknown. Therefore, in this study we asked whether decreasing the amount of eIF2α phosphorylation by genetically removing either PERK or GCN2 could prevent Alzheimer's disease-associated impairments in synaptic plasticity and memory. We found that suppressing the expression either PERK or GCN2 decreased elevated phosphorylation of eIF2α as well as deficits in synaptic plasticity and impairments in memory exhibited by Alzheimer's disease model mice. Our findings implicate elevated phosphorylation of eIF2α as a contributor to Alzheimer's disease-related synaptic pathophysiology and suggest that PERK and/or GCN2 could be therapeutic targets to ameliorate synaptic and memory dysfunction in individuals with Alzheimer's disease.
RESULTS

Reducing PERK prevents Ab-induced impairment in plasticity
We first examined the state of eIF2α phosphorylation in various brain regions from 10-12-month-old transgenic mice (APPswe,PSEN1dE9) that express familial Alzheimer's disease-related mutant APP (Swedish mutation) and mutant presenilin 1 (PSEN1 with a deletion of exon 9) 15 ; here we refer to these Alzheimer's disease model mice as APP-PS1 mice. Using western blots, we analyzed eIF2α phosphorylation at Ser51, which is targeted by all four eIF2α kinases 11 . In these model mice, compared to wild-type mice, we observed an increase in the amounts of phosphorylated eIF2α in the hippocampus (150.60 ± 24.26% of the amount in wild type; Fig. 1a ) and prefrontal cortex (data not shown) but not in the cerebellum (76.96 ± 10.71% of the amount in wild type; Fig. 1b ). We also examined the hippocampus in brain sections from postmortem human Alzheimer's disease patients by western blots and immunohistochemistry. Consistent with the above data from APP-PS1 mice and previous findings in other Alzheimer's disease model mice [5] [6] [7] , we observed increased amounts a r t I C l e S of phosphorylated eIF2α in the hippocampus from Alzheimer's disease patients compared to age-matched controls (273.30 ± 35.72% of amount in age-matched controls; Fig. 1c,d) . In agreement with the increased amount of phosphorylated eIF2α in Alzheimer's disease model mice compared to that in wild-type mice, we also observed increased levels of ATF4, a repressor of long-lasting long-term potentiation (LTP) and long-term memory 8 , in the hippocampus of APP-PS1 mice (184.42 ± 39.72% of the amount in wild type; Fig. 1e ). Thus, eIF2α phosphorylation is abnormally elevated in Alzheimer's disease.
We subsequently investigated whether Alzheimer's diseaseassociated impairments in synaptic plasticity and memory could be alleviated by lowering eIF2α phosphorylation. Among the kinases for eIF2α, PERK activity is usually associated with endoplasmic reticulum stress, which has been implicated in Alzheimer's disease 9 . Therefore, we posited that PERK-induced eIF2α phosphorylation and the subsequent suppression of de novo protein synthesis may be a consequence of endoplasmic reticulum stress in Alzheimer's disease. First, we bred mice harboring a loxP-flanked Eif2ak3 gene 16 with mice expressing a brain-specific Cre recombinase 17 to generate mice in which Eif2ak3, which encodes PERK, was conditionally removed in excitatory neurons in the forebrain and hippocampus late in development ( Supplementary Fig. 1a ) 18 . Next, using immunofluorescence combined with confocal microscopy, we observed punctate colocalization of PERK and phosphorylated eIF2α in dendrites of adult mouse hippocampal neurons in culture ( Supplementary Fig. 1b ). We proceeded to examine the Aβ-dependent regulation of eIF2α phosphorylation in wild-type mice. Consistent with recent findings 18 , in slices from wild-type mice, LTP-inducing high-frequency stimulation (HFS) caused dephosphorylation of eIF2α, which was prevented by addition of exogenous Aβ ( Fig. 2a) . To acquire direct evidence for Aβ-mediated effects on protein synthesis, we used surface sensing of translation (SUnSET), a method that does not rely on radioactivity to monitor new protein synthesis 19 . In agreement with its ability to blunt eIF2α dephosphorylation, Aβ blocked HFS-induced increases in de novo protein synthesis ( Fig. 2b) . We then applied exogenous Aβ to hippocampal slices and induced LTP in area CA1 by HFS. In the presence of Aβ, LTP was inhibited in slices from wild-type mice but was not affected in slices prepared from PERK conditional mutant mice ( Fig. 2c,d) . Removal of PERK itself did not affect hippocampal synaptic plasticity, as HFS induced similar LTP in slices from either wild-type or PERK mutant mice ( Fig. 2c,d) . In contrast, coapplication of Aβ and Sal003, an inhibitor of eIF2α dephosphorylation 8 , resulted in LTP failure in PERK mutant mice ( Fig. 2c,d) . Taken together, these results indicate that Aβ-induced impairments in hippocampal synaptic plasticity are alleviated by deleting PERK.
Reducing PERK corrects abnormalities in APP-PS1 mice
We then generated a APP-PS1 mouse line that also expressed homozygous Camk2a-cre-Eif2ak3 loxP/loxP transgenes. The breeding strategy (a,b) Western blot analyses of eIF2α phosphorylation (p-eIF2α) in the following brain areas of wild type and APP-PS1 Alzheimer's disease model mice: hippocampus (a; n = 7 mice for both groups; P = 0.041, independent two-tailed t-test) and cerebellum (b; n = 11 for WT and n = 10 for APP-PS1; P = 0.080). (c) Western blot analysis of eIF2α phosphorylation in postmortem human Alzheimer's disease brain samples and those of age-matched controls (CT) (n = 4 for both groups; P = 0.012, independent two-tailed t-test). (d) Diaminobenzidine staining to assay eIF2α phosphorylation in the hippocampus of postmortem human Alzheimer's disease brain (AD) and control (representative of three independent experiments). Scale bars, 150 µm. (e) Western blot analysis of ATF4 levels in the hippocampus of APP-PS1 mice and WT littermates (n = 6 for each group; P = 0.044, independent two-tailed t-test). Full-length blots and gels are in Supplementary Figure 8 . npg a r t I C l e S involved two stages: generation of APP-PSI female mice with heterozygous Camk2a-cre-Eif2ak3 +/loxP transgenes followed by breeding with male heterozygous Eif2ak3 +/loxP mice. All mice generated for these experiments were 10-12 months old, an age when APP-PS1 mice reliably exhibit synaptic dysfunction and memory deficits 20, 21 . After ~18 months of breeding, we obtained a sufficient number of APP-PS1 PERK conditional mutant mice (APP-PS1 Camk2a-cre-Eif2ak3 loxP/loxP ), along with three other littermate groups for experiments ( Fig. 3a) : Camk2a-cre only (here referred to as wild type), APP-PS1 and Camk2a-cre-Eif2ak3 loxP/loxP . Consistent with decreased expression of PERK, the increased phosphorylation of eIF2α in the APP-PS1 mice was lower in hippocampus and prefrontal cortex of APP-PS1 PERK conditional mutant mice (Fig. 3b,c and Supplementary Fig. 2a,b) . In contrast, phosphorylation of eIF2α and the expression of PERK in the cerebellum were indistinguishable between the four groups of mice ( Supplementary  Fig. 2c,d) . To examine the effects of removing PERK on protein synthesis in Alzheimer's disease model mice, we performed SUnSET experiments on hippocampal slices and observed that amounts of newly synthesized proteins were lower in APP-PS1 mice compared to wild-type littermates ( Fig. 3d,e ). Consistent with the restoration of eIF2α phosphorylation (Fig. 3b) , the drop in protein synthesis was prevented in APP-PS1 PERK conditional mutant mice ( Fig. 3d,e ). We also examined the expression of ATF4 and CHOP (also termed GADD153), both of which have been shown to be downstream of eIF2α phosphorylation after cellular stress in nonneuronal systems 22 . We detected downregulation of ATF4 expression, but no alteration in CHOP expression in APP-PS1 PERK conditional mutant mice when compared to APP-PS1 mice ( Fig. 3f and Supplementary Fig. 2e ), suggesting that expression of ATF4 and CHOP proteins might be differentially regulated in the mouse brains 22, 23 . Thus, dysregulation of eIF2α phosphorylation and de novo protein synthesis in APP-PS1 mice are corrected by the conditional removal of PERK.
We next tested spatial learning and memory of the four genotypes of mice described above on three independent behavioral tasks: Morris water maze (MWM), object location and Y water maze (YWM). During acquisition of the hidden platform version of MWM, wild-type mice showed a day-to-day decrease in escape latency, whereas APP-PS1 mice exhibited longer escape latencies ( Fig. 4a) . Compared to wild-type mice, APP-PS1 mice spent less time in the target quadrant and crossed the platform location fewer times in probe tests when the platform was removed (Fig. 4b,c) . Notably, the impaired learning and memory deficits exhibited by APP-PS1 mice were not exhibited by APP-PS1 PERK conditional mutant mice, as indicated by diminished escape latency, increased target quadrant occupation and more platform crossings that were comparable to those exhibited by wild-type mice ( Fig. 4a-c) . Of note and consistent with previous findings 18 , the performance of PERK conditional mutant mice was not different from that of wild-type mice in the MWM test ( Fig. 4a-c) , suggesting that the decrease in the amount of PERK does not alter hippocampus-dependent spatial memory in this task. To investigate the possibility that the learning and memory improvements exhibited by APP-PS1 PERK conditional mutant mice were attributable to effects on vision, motivation or swimming ability, we tested mice on the visible platform task and found no observable differences between the four groups of mice in their latency to find the visible platform ( Fig. 4d) . In agreement, the results from the object location and YWM tasks also indicate that spatial memory impairments associated with APP-PS1 mice were not displayed by APP-PS1 PERK conditional mutant mice ( Fig. 4e,f) . These behavioral studies indicate that spatial memory defects in APP-PS1 mice were prevented by normalizing PERK-eIF2α signaling.
The onset of sporadic Alzheimer's disease is age-dependent, and it has been proposed that increased eIF2α phosphorylation in response to acute and/or early accumulation of Aβ could be protective 14 . Therefore, we determined whether diminishing PERK-eIF2α signaling impacted the spatial memory of APP-PS1 mice at a younger age. We performed MWM tests on mice at 3-5 months of age and observed no significant (ANOVA, P = 0.1423, F = 2.188) differences in escape latency, target quadrant occupation or platform crossings between the four groups of mice ( Supplementary  Fig. 3a-c) . These findings suggest that suppressing PERK-eIF2α npg a r t I C l e S signaling does not affect spatial learning and memory performance in young Alzheimer's disease model mice. We next determined whether deleting PERK could rescue synaptic plasticity deficits in 10-12-month-old APP-PS1 mice. LTP was dramatically lower in APP-PS1 mice, and the removal of PERK resulted in normal LTP in the APP-PS1 PERK conditional mutant mice (Fig. 5a,b) . LTP was not altered in the PERK conditional mutant mice (Fig. 5a,b) . To determine whether restored LTP in the APP-PS1 PERK conditional mutant mice was dependent on protein synthesis, we induced LTP in the presence of the general protein synthesis inhibitor anisomycin. Treatment of slices from wild-type mice with anisomycin (40 µM) resulted in inhibition of LTP compared to vehicletreated control slices (Fig. 5c) . LTP in APP-PS1 PERK conditional mutant mice also was inhibited by anisomycin ( Fig. 5c) , indicating that the conditional deletion of PERK resulted in restored LTP that was dependent on protein synthesis. We then investigated the effects of diminishing PERK-eIF2α signaling on amyloidogenesis. Compared with APP-PS1 mice, which had considerable amounts of Aβ deposits in the brain, Aβ amounts were lower in the hippocampus of APP-PS1 PERK conditional mutant mice (Fig. 5d) . The decrease in the brain Aβ load was not due to effects on APP expression, as amounts of full-length APP were not changed (Fig. 5d) . Moreover, we observed less beta C-terminal fragment but not alpha C-terminal fragment of APP in the hippocampus of APP-PS1 PERK conditional mutant mice (Fig. 5e) . We observed no significant changes in the amounts of the APP cleavage enzymes BACE1 or γ-secretase as reflected by unaltered amounts of PEN2, an essential component of γ-secretase complex (Supplementary Fig. 4a,b) . Consistent with previous findings 24 , we observed a decrease in the amount Aβ degrading enzyme neprilysin in the hippocampus of the APP-PS1 mice, which was corrected in the APP-PS1 PERK conditional mutant mice (Fig. 5f) .
To analyze the molecular mechanisms associated with the effects of the conditional deletion of PERK on APP-PS1 mice, we examined regulation of proteins that have been implicated in synaptic plasticity and memory, including activity-regulated cytoskeleton-associated protein (Arc), calcium/calmodulin-dependent protein kinase II (CaMKII), AMPA receptor subunit GluA1 and protein kinase M zeta (PKMζ) [25] [26] [27] . We observed less of both Arc and PKMζ in hippocampal area CA1 in APP-PS1 mice, which was corrected by the conditional deletion of PERK (Fig. 5g,h) . However, levels of CaMKII and GluA1 were not changed ( Fig. 5g,h) . Finally, we observed increased amounts of PSD-95 and decreased amounts of synaptophysin in the APP-PS1 mice compared to wild-type mice, in agreement with previous studies 28 . Amounts of these synaptic proteins were restored in the APP-PS1 PERK conditional mutant mice to levels indistinguishable from those in wild-type littermates (Fig. 5g,h and Supplementary  Fig. 5e,f) . We also examined the amounts of other proteins that could be involved in the regulation of PERK-eIF2α signaling, such as type 1 protein phosphatase (PP1), which contributes to dephosphorylation of eIF2α (ref. 29 ), transcription factor Nrf2, which has been shown in non-neuronal cells to be a substrate of PERK 30 , and the unfolded protein response markers ATF6 and IRE1α (ref. 31 ). However, none of the aforementioned proteins were altered across the four mouse genotypes (Supplementary Fig. 5a-d) . Thus, the decrease in PERK-eIF2α signaling in APP-PS1 mice diminished amyloidogenesis and restored physiological amounts of neprilysin as well as of the plasticity-related and memory-related proteins Arc and PKMζ.
Reducing GCN2 amount corrects abnormalities in APP-PS1 mice
To further analyze the role of eIF2α phosphorylation in Alzheimer's disease-associated impairments of synaptic plasticity and memory, we performed LTP experiments on hippocampal slices from a mouse line in which Eif2ak4, which encodes another eIF2α kinase, GCN2, was globally and constitutively removed 32 . Similar to the experiments with PERK conditional mutant mice, slices from mice that lack GCN2 treated with exogenous Aβ(1-42) still expressed LTP (Fig. 6a,b) . Of note, unlike the case in PERK conditional mutant mice, there was a trend of enhanced LTP in the GCN2-deficient mice (Fig. 6a,b) . In addition, consistent with the experiments with PERK conditional mutant mice, coapplication of Aβ and Sal003 resulted in LTP failure in GCN2-deficient mice (Fig. 6a,b) . Taken together, these results suggest that suppressing GCN2 prevents Aβ-induced synaptic plasticity impairments by diminishing eIF2α phosphorylation.
Next we crossed APP-PS1 mice with GCN2-deficient mice to generate APP-PS1 GCN2-deficient mice and aged them for 10-12 months before conducting the following experiments. First, we confirmed that the abnormally high eIF2α phosphorylation and ATF4 expression in the hippocampus of APP-PS1 mice were restored in APP-PS1 GCN2-deficient mice to the levels observed in wild-type mice (Supplementary Fig. 6a,b) . Phosphorylation of eIF2α in a r t I C l e S GCN2-deficient mice was not different from that in wild-type mice (Supplementary Fig. 6a,b) . Consistent with the biochemical findings, we found that hippocampal LTP deficits in APP-PS1 mice were normalized in APP-PS1 GCN2-deficient mice (Fig. 6c-e ).
We then tested the behavioral effects of removing GCN2 in the APP-PS1 mice by performing the MWM task to access spatial learning and memory. Similar to the observations from the studies with the APP-PS1 PERK conditional mutant mice, the impairments in spatial npg a r t I C l e S learning and memory displayed by the 10-12-month-old APP-PS1 mice were prevented in the APP-PS1 GCN2-deficient mice as indicated by decreased escape latency, increased platform crossings as well as target quadrant occupancy that were close to those displayed by wild-type mice (Fig. 7a-c) . In addition, the improvements in learning and memory displayed by the APP-PS1 GCN2-deficient mice were not due to effects on vision, motivation or swimming ability, as demonstrated in visible platform task, which showed no difference between groups (Fig. 7d) . Taken together, these findings indicate that genetic removal of the eIF2α kinase GCN2 prevents Alzheimer's disease-associated LTP failure and spatial memory impairments.
DISCUSSION
Identifying molecular mechanisms underlying synaptic failure and memory loss associated with Alzheimer's disease could provide the basis for new therapeutics for the treatment of this devastating neurodegenerative disease. De novo protein synthesis is key in longlasting synaptic plasticity and long-term memory 5, 6, 33 . As a translational factor controlling general protein synthesis, eIF2α, through modulation of its phosphorylation state, is important in maintaining long-lasting forms of synaptic plasticity and long-term memory [7] [8] [9] .
Here we showed that diminishing eIF2α phosphorylation, via forebrain-specific conditional deletion PERK, one of its kinases, protected mice from Alzheimer's disease-related deficits in synaptic plasticity and spatial memory, which was correlated with decreased amyloidogenesis and restoration of normal expression of plasticity-related proteins. Also, deletion of the gene encoding GCN2, another eIF2α kinase, also prevented Alzheimer's disease-related deficits in synaptic plasticity and spatial memory, which also is likely due to the resetting of eIF2α phosphorylation and normal translational homeostasis (Supplementary Fig. 7) .
Phosphorylation of eIF2a by PERK: a double-edged sword?
In normal physiological situations, phosphorylation of eIF2α usually is considered to be protective. In response to a wide range of cellular stressors, eIF2α is phosphorylated by one of its four kinases, which includes PERK, leading to inhibition of general mRNA translation, but also increased translation of selected mRNAs, including that encoding ATF4. The decrease in the amount of general protein synthesis allows cells to conserve energy resources, and enhanced translation of selected mRNAs increases expression of stress-related proteins, thereby reconfiguring gene expression to manage the stress condition 11, 34, 35 . This type of mechanism might account for the late onset of synaptic failure and memory deficits observed in sporadic Alzheimer's disease (the majority of Alzheimer's disease) and in most Alzheimer's disease model mice. Therefore, we hypothesized that the deletion of PERK in APP-PS1 mice early in life might be detrimental to memory formation. However, we did not observe any change in the spatial memory of young APP-PS1 PERK conditional knockout mice (Supplementary Fig. 3a-c) , suggesting that another eIF2α kinase may be responsible for maintaining translational homeostasis. In contrast, in later stages of pathophysiologies associated with neurodegenerative diseases, abnormally high levels of stress-inducing agents such reactive oxygen species are likely generated constantly, overwhelming the ability of the endogenous antioxidant mechanisms to remove them 36, 37 , which then results in unusually high levels of eIF2α phosphorylation. In other words, the fine balance between new protein synthesis and the stress response, which is intact under normal physiological conditions, is likely to be disrupted permanently in later stages of Alzheimer's disease, making the dysregulation of protein synthesis more pronounced and longer lasting than in the initial stages of the disease. This long-term disruption of translational homeostasis will inevitably hinder long-lasting synaptic plasticity and long-term memory because de novo protein synthesis is essential for both processes 33, 38 . Notably, it was shown recently that mice treated with a compound that inhibits the downstream consequences of eIF2α phosphorylation exhibit enhanced learning and memory 39 , consistent with the idea that eIF2α phosphorylation limits memory formation. eIF2a phosphorylation in Alzheimer's disease The four kinases that phosphorylate eIF2α, PERK, GCN2, PKR and HRI, typically are classified by their response to a specific type of cellular stress, each of which activates a single kinase. However, the idea that each eIF2α kinase responds to only one type of stressor is almost certainly oversimplified 11, 35 . Studies have indicated that during conditions such as oxidative stress, multiple eIF2α kinases, especially PERK and GCN2, are recruited either simultaneously or sequentially to reset cellular homeostasis [40] [41] [42] . In agreement, we showed here that deletion of either PERK or GCN2 can correct eIF2α hyperphosphorylation, presumably induced by several cellular stressors, as well as synaptic plasticity and memory deficits exhibited by Alzheimer's disease model mice. Our studies revealed that although removal of PERK by itself resulted in decreased basal phosphorylation of eIF2α, removal of GCN2 alone had no effect on basal eIF2α phosphorylation. Moreover, deletion of Eif2ak2, which encodes the eIF2α kinase PKR, also did not alter the basal phosphorylation of eIF2α ( Supplementary Fig. 1c,d) . Taken together, these findings suggest a dominant role for PERK in controlling the basal state of eIF2α phosphorylation in brain.
Although our current study focused on eIF2α kinases, dephosphorylation of eIF2α, by phosphatases such as protein phosphatase 1 (ref. 29 Figure 7 Spatial memory deficits in APP-PS1 Alzheimer's disease model mice are alleviated by deleting the eIF2α kinase GCN2. (a) Escape latency in the Morris water maze plotted against the training days. Wild-type (WT) mice (n = 9), APP-PS1 mice (n = 8), GCN2-deficient (GCN2 KO) mice (n = 12) and APP-PS1 GCN2 KO (n = 9). Repeated measures ANOVA followed by a post hoc Bonferroni multiple-comparison test, P = 0.0014, F 3,37 = 9.960. APP-PS1 versus WT: P < 0.01, t = 4.532; APP-PS1 versus APP-PS1 GCN2 KO: P < 0.05, t = 3.360; APP-PS1 GCN2 KO versus WT: P > 0.05, t = 1.172. (b) Percentage of time spent in the target quadrant during a 60 s probe trial of MWM test. One-way ANOVA, P = 0.0261, F = 3.584. (c) Frequency of platform crossing during a 60 s probe trial of MWM test. Oneway ANOVA, P = 0.0144, F = 4.057. APP-PS1 versus APP-PS1 GCN2 KO: P = 0.0526. **P < 0.01. (d) Escape latencies for the visible platform test for the four genotypes (repeated measures ANOVA, P = 0.3735, F = 1.500). Error bars, s.e.m. a r t I C l e S plasticity and memory. Future studies will be necessary to better understand how the disruption of translational homeostasis is involved in Alzheimer's disease pathophysiology. In brief, given the general requirement of de novo protein synthesis for long-lasting synaptic plasticity and long-term memory consolidation, and in light of recent findings demonstrating that hyperphosphorylation of eIF2α is associated with synaptic deficits and neuronal loss in prion-disease model mice 43 , it is possible that the dysregulation of eIF2α phosphorylation is a common molecular mechanism underlying diseases characterized by neurodegeneration and memory dysfunction. Thus, both PERK and GCN2 have potential as new therapeutic targets not only for Alzheimer's disease and prion disease but also for diseases such as frontotemporal dementia and Lewy body disease.
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